BrainScan CT is an AI-powered radiology tool that analyzes brain CT scans to detect and classify 30 key pathologies, covering over 90% of findings in non-contrast imaging with up to 99% accuracy for hemorrhages.
Ludwig Maximilian University (LMU) Hospital used a mobile CT scanner with AI algorithms at the 2024 Munich Oktoberfest to diagnose intracranial hemorrhages from head trauma, improving emergency diagnostic efficiency.
BrainScan secured €2.5 million from the Polish Agency for Enterprise Development (PARP) to develop its multimodal diagnostic platform and became a publicly traded company on the Warsaw Stock Exchange’s NewConnect market.
BrainScan S.A. has received €2.64 million in funding from the Polish Agency for Enterprise Development under the SMART Pathway program (FENG.01.01-IP.02-002/23). The project, titled “Multimodal system for automated diagnosis support of brain pathologies in computed tomography,” is valued at approximately €3.81 million (at an approximate exchange rate of 1 EUR = 4.2 PLN) and will